Visine
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Visine ( ), also known as Vispring, is a brand of eye drops produced by Kenvue. Visine was first introduced in 1958 and was acquired by Pfizer in 1999. In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. The original formulation of Visine includes the active ingredient tetrahydrozoline hydrochloride, which is a vasoconstrictor that constricts the eye's superficial blood vessels to temporarily reduce eye redness.
Visine ( ), also known as Vispring, is a brand of eye drops produced by Kenvue. Visine was first introduced in 1958 and was acquired by Pfizer in 1999. In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. The original formulation of Visine includes the active ingredient tetrahydrozoline hydrochloride, which is a vasoconstrictor that constricts the eye's superficial blood vessels to temporarily reduce eye redness.
Products
In addition to its original formulation, Visine is available in several varieties of eye drops for different types of eye irritation. These include formulas with antihistamines for allergy-induced irritation, to moisturizing formulations for eye dryness. These formulations use active ingredients ranging from oxymetazoline to naphazoline. Some Visine products cater specifically to contact lens wearers or to those who require artificial tears.
Side effects
Adverse effects
Visine has been observed to cause stinging and burning upon application, and has a rebound effect that may cause eye redness to worsen. Prolonged use has been observed to cause blood vessels to be dilated for an extended period of time. Because of this risk, Visine usage has been recommended to be limited, unless specified by a doctor. Some formulations of Visine are not advised for contact lens wearers as the decreased blood flow to counter eye redness could further lower oxygen levels to the eye. Some Visine products are not recommended to be used by patients with glaucoma, since stimulation from lubrication can contribute to high pressure within the eye. Certain underlying health conditions that cause eye irritation are not able to be relieved by Visine and require prescription-grade eye drops.
References
External links
Visine webpage Snopes reference
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359181197 under CC BY-SA 4.0; modifications have been made.